Phase 3 Program: TRIUMPH Trials (20252026) The Phase 3 TRIUMPH investigational program is one of the most extensive registrational programs ever undertaken for a metabolic compound, with ongoing trials in obesity with comorbidities, type 2 diabetes, knee osteoarthritis, obstructive sleep apnea, chronic low back pain, cardiovascular outcomes, and MASLD
Progressive decrease of cerebral cytochrome C oxidase activity in sparse-fur mice: role of acetyl-L-carnitine in restoring the ammonia-induced cerebral energy depletion Neurosci Lett 1997
The sulforaphane in HM Complex is derived from a standardized broccoli sprout concentrate
Acetaminophen is primarily metabolized by conjugation with sulfate and glucuronide
Finally, the inclusion of specific trace minerals provides targeted defense against heavy metal toxicity
As of May 2026, BPC-157 dietary supplements remain available for purchase in the United States